Scott Gottlieb abruptly resigned his post as FDA Commissioner March 5, effective in one month.
The news came as a surprise to agency watchers. In his 22 months on the job, Gottlieb has instituted some significant reorganizations, and he is generally viewed as one of the more popular agency officials in the Trump administration
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Medtech Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?